We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche’s Gazyva Gives Leukemia Patients Extra Year Over Rituxan
Roche’s Gazyva Gives Leukemia Patients Extra Year Over Rituxan
November 7, 2013
In a clinical trial, Roche’s Gazyva added almost a year to the lives of patients with chronic lymphocytic leukemia. BusinessWeek
